What is the appropriate dosage of glucagon for pediatric patients unable to receive oral glucose or IV treatment?

The appropriate dosage of glucagon in pediatric patients who are unable to receive oral glucose or intravenous treatment varies based on body weight, making the correct choice particularly important for effective treatment. For pediatric patients weighing less than 20 kg, a dose of 0.5 mg administered intramuscularly (IM) is recommended due to their smaller body mass and the need to avoid overdosing. For those weighing more than 20 kg, a dose of 1 mg IM is indicated, as their larger body size allows for a higher dose that can effectively elevate blood glucose levels.

This weight-based dosing is crucial because it helps tailor the treatment to the individual patient's needs, optimizing efficacy while minimizing the risk of adverse effects. Providing the appropriate dosage for different weight categories ensures that each patient receives a safe and effective amount of glucagon to counteract severe hypoglycemia when alternative routes of glucose administration are not feasible.